A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This is a multi-center, open-label study of 28 weeks duration in subjects with Mild Cognitive Impairment who have completed the double-blind study (E2020-A001-412).
Epistemonikos ID: 47cdf9f042e2e6dfe858ec23a23339701eaa2490
First added on: May 05, 2024